WO2010077061A2 - 항바이러스성 약물을 포함하는 약제학적 제제 - Google Patents
항바이러스성 약물을 포함하는 약제학적 제제 Download PDFInfo
- Publication number
- WO2010077061A2 WO2010077061A2 PCT/KR2009/007880 KR2009007880W WO2010077061A2 WO 2010077061 A2 WO2010077061 A2 WO 2010077061A2 KR 2009007880 W KR2009007880 W KR 2009007880W WO 2010077061 A2 WO2010077061 A2 WO 2010077061A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- antiviral drugs
- pharmaceutical formulations
- drugs
- formulations containing
- containing antiviral
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Abstract
본 발명은 항바이러스성 약물 및 지연방출물질을 포함하는 약제학적 제제와 사이토크롬 P450 관련 약물을 포함하는 선방출성 구획, 및 항바이러스성 약물 및 지연방출물질을 포함하는 지연방출성 구획을 포함하는 약제학적 제제를 제공하며, 본 발명의 제제는 항바이러스성 약물의 상호작용을 감소시켜 약효를 증가시키고 부 작용을 감소시킬 수 있다는 장점을 갖는다.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14198308P | 2008-12-31 | 2008-12-31 | |
US61/141,983 | 2008-12-31 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2010077061A2 true WO2010077061A2 (ko) | 2010-07-08 |
WO2010077061A3 WO2010077061A3 (ko) | 2010-11-04 |
Family
ID=42310377
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2009/007880 WO2010077061A2 (ko) | 2008-12-31 | 2009-12-29 | 항바이러스성 약물을 포함하는 약제학적 제제 |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2010077061A2 (ko) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030099706A1 (en) * | 2000-10-13 | 2003-05-29 | Rudnic Edward M. | Antiviral product, use and formulation thereof |
US20060003005A1 (en) * | 2004-07-02 | 2006-01-05 | Bruce Cao | Tablet for pulsed delivery |
US7074417B2 (en) * | 2000-10-13 | 2006-07-11 | Advancis Pharmaceutical Corporation | Multiple-delayed release anti-viral product, use and formulation thereof |
US20060204578A1 (en) * | 2001-11-06 | 2006-09-14 | Vergez Juan A | Dual controlled release dosage form |
KR100824547B1 (ko) * | 1995-06-29 | 2008-11-04 | 아보트 러보러터리즈 | 사이토크롬p450에의해대사되는약물의약력학을개선하기위한리토나비르(abt-538)의용도 |
-
2009
- 2009-12-29 WO PCT/KR2009/007880 patent/WO2010077061A2/ko active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100824547B1 (ko) * | 1995-06-29 | 2008-11-04 | 아보트 러보러터리즈 | 사이토크롬p450에의해대사되는약물의약력학을개선하기위한리토나비르(abt-538)의용도 |
US20030099706A1 (en) * | 2000-10-13 | 2003-05-29 | Rudnic Edward M. | Antiviral product, use and formulation thereof |
US7074417B2 (en) * | 2000-10-13 | 2006-07-11 | Advancis Pharmaceutical Corporation | Multiple-delayed release anti-viral product, use and formulation thereof |
US20060204578A1 (en) * | 2001-11-06 | 2006-09-14 | Vergez Juan A | Dual controlled release dosage form |
US20060003005A1 (en) * | 2004-07-02 | 2006-01-05 | Bruce Cao | Tablet for pulsed delivery |
Also Published As
Publication number | Publication date |
---|---|
WO2010077061A3 (ko) | 2010-11-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2009111653A3 (en) | Antiviral therapeutic agents | |
WO2010036407A3 (en) | Antiviral nucleoside analogs | |
EP2251038A4 (en) | SOLID DISPERSION, PHARMACEUTICAL COMPOSITIONS THEREFOR AND METHOD FOR THE PRODUCTION THEREOF | |
WO2010000877A3 (en) | Formulation with irritation reducing action comprising bisabolol and [6]-paradol | |
WO2008132229A3 (en) | Highly concentrated insulin solutions and compositions | |
WO2010077740A3 (en) | Novel antiviral compounds, compositions, and methods of use | |
WO2011051971A3 (en) | Solid dispersion of rifaximin | |
MX2010010407A (es) | Derivados de 4-aminociclohexanos sustituidos. | |
ZA200809864B (en) | Pharmaceutical formulations for the sustained release of active ingredients(s), as well as their applications, especially therapeutic | |
WO2009117130A3 (en) | Extended release forumulation containing a wax | |
WO2009121039A3 (en) | Administration of benzodiazepine compositions | |
IL210549A (en) | Pipedrine - Quinocosalin-Mediated Conjugated Drugs | |
WO2009135646A3 (en) | Stable pharmaceutical compositions and their processes for preparation suitable for industrial scale | |
WO2009115084A3 (de) | Pyrrolopyrimidin-derivate und deren verwendungen | |
HK1172845A1 (en) | Novel pharmaceutical formulations against drug misuse | |
WO2008017346A3 (de) | Ascorbinsäurederivate, verwendung zur funktionalisierung von matrices | |
WO2010021607A3 (en) | Pharmaceutical formulation | |
WO2009135593A3 (de) | Feste arzneimittelformulierung mit verzögerter freisetzung | |
WO2011009938A3 (en) | Stambomycin and derivatives, their production and their use as drugs | |
EP2241569A4 (en) | THIENOPYRIDAZINE COMPOUNDS, PREPARATIONS THEREOF, PHARMACEUTICAL COMPOSITIONS AND USES | |
WO2010049449A3 (en) | Novel salts of sunitinib | |
WO2011054837A3 (de) | Bifunktionale prodrugs und drugs | |
TN2009000510A1 (en) | Extended release formulation of nevirapine | |
WO2010065586A3 (en) | Preparation of capecitabine | |
WO2010046061A3 (de) | Kosmetische und/oder pharmazeutische zubereitungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09836382 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase in: |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 09836382 Country of ref document: EP Kind code of ref document: A2 |